Kyverna Therapeutics, Inc. Quarterly Stockholders' Equity Attributable to Parent in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Kyverna Therapeutics, Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2022 to Q3 2024.
  • Kyverna Therapeutics, Inc. Stockholders' Equity Attributable to Parent for the quarter ending September 30, 2024 was $303M.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $303M +$415M Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $334M +$431M Jun 30, 2024 10-Q 2024-11-13
Q1 2024 $361M +$446M Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$131M -$57.4M -77.6% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 -$112M Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$97.2M Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$84.6M Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$74M Dec 31, 2022 10-Q 2024-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.